Emerging treatment of atopic dermatitis
Journal
Clinical Reviews in Allergy and Immunology
Journal Volume
33
Journal Issue
3
Pages
199-203
Date Issued
2007
Author(s)
Abstract
Atopic dermatitis is a chronically relapsing eczematous disease of the skin. A wide range of therapeutic regimens has been used for atopic dermatitis. A better understanding of its pathogenesis will also lead to the development of novel approaches to treating this disease. This article reviews the recent advances in allergen-specific sublingual immunotherapy and therapy with antileukotriene drugs, probiotics, mycophenolate mofetil, leflunomide, and intermittent fluticasone propionate ointment, which the authors expect will be clinically useful therapies in the near future. ? 2007 Humana Press Inc.
Subjects
Atopic dermatitis; Fluticasone propionate; Leflunomide; Leukotriene antagonists; Mycophenolate mofetil; Probiotic; Sublingual immunotherapy
SDGs
Other Subjects
azathioprine; corticosteroid; cyclosporin; fluticasone propionate; glucocorticoid; hydrocortisone; hydrocortisone butyrate; immunomodulating agent; leflunomide; leukotriene receptor blocking agent; montelukast; mycophenolic acid 2 morpholinoethyl ester; pranlukast; probiotic agent; zafirlukast; zileuton; asthma; atopic dermatitis; clinical trial; disease association; disease severity; drug effect; drug efficacy; drug mechanism; drug tolerability; human; maintenance therapy; milk allergy; review; unspecified side effect; Androstadienes; Animals; Dermatitis, Atopic; Desensitization, Immunologic; Histamine H1 Antagonists; Humans; Immunosuppressive Agents; Isoxazoles; Leukotriene Antagonists; Mycophenolic Acid; T-Lymphocytes, Regulatory
Type
journal article